Dr Frankel talks about Trigeminal Neuralgia and the positive effect he has seen cannabis have on patients dealing with it. Some feedback received by three recent patients is also included.
My first clinical experiences with Cannabidiol (CBD) and Type II Diabetes were generally with patients who were on Metformin. Within a couple of days of starting CBD the patients had a tendency to become hypoglycemic. After consultation with me and their primary care doctor, working together, most of these early patients ended up stopping their Metformin and continuing with cannabidiol. Generally, over the next six months, most of these patients had lower Hemoglobin A1C.
Now I see patients who come in specifically to help their Diabetes. It is of course not just for glucose control. It is for treatment of their neuropathy and obesity. There are some early studies, with links at end of this article, showing retinal protection may also be a real benefit. As diabetes is such a multi system disease, adding CBD along with the patients’ other regimens can only be helpful.
We are just talking about a plant extract that is highly neuro protective, often normalizes serum glucose and helps the patient lose weight.
Not much to lose. These should keep you busy:
You Might Also Enjoy...
Dr Frankel talks about his experience with prostate cancer therapies that have reduced his testosterone and the effect it has had on his life.
With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.
There are "acid" and "neutral" forms of every cannabinoid molecule. Early man knew the difference and would either just eat the cannabis raw, or heat it to convert to the neutral or "active" forms of the cannabinoids.
Cookie Bekkar is a cancer survivor and patient of Dr Frankel's. She has created a website to share her story, what worked well for her and as a resource help inspire/educate other patients.
Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.